Samantha Pearce's most recent trade in Jazz Pharmaceuticals plc was a trade of 577 Ordinary Shares done at an average price of $116.1 . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.10 per share. | 05 Aug 2025 | 577 | 40,815 (0%) | 0% | 116.1 | 66,990 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 138.95 per share. | 05 Mar 2025 | 1,905 | 41,226 (0%) | 0% | 139.0 | 264,700 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 11,941 | 37,353 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,778 | 43,131 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 2,533 | 26,777 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.62 per share. | 17 Jan 2025 | 1,365 | 25,412 (0%) | 0% | 122.6 | 167,376 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 6,996 | 24,078 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.53 per share. | 05 Mar 2024 | 2,474 | 16,922 (0%) | 0% | 117.5 | 290,769 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,065 | 19,396 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Pearce Samantha | SVP, Head of Europe & Internat | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 2,210 | 15,369 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Pearce Samantha | SVP, Head of Europe & Internat | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.13 per share. | 17 Jan 2024 | 1,038 | 14,331 (0%) | 0% | 119.1 | 123,657 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 3,870 | 15,179 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.78 per share. | 03 Mar 2023 | 2,020 | 13,159 (0%) | 0% | 142.8 | 288,416 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 157.26 per share. | 02 Feb 2023 | 531 | 11,309 (0%) | 0% | 157.3 | 83,505 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 531 | 6,907 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 02 Feb 2023 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 531 | 7,438 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 159.59 per share. | 03 Jan 2023 | 531 | 11,309 (0%) | 0% | 159.6 | 84,742 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 03 Jan 2023 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 531 | 7,969 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.45 per share. | 13 Dec 2022 | 531 | 11,309 (0%) | 0% | 155.5 | 82,544 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 13 Dec 2022 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 532 | 9,031 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 10 Nov 2022 | 532 | 11,309 (0%) | 0% | 155 | 82,460 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 10 Nov 2022 | 532 | 11,841 (0%) | 0% | 109.4 | 58,227 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 531 | 8,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 10 Nov 2022 | 531 | 11,309 (0%) | 0% | 155 | 82,305 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 10 Nov 2022 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 156.98 per share. | 02 Sep 2022 | 531 | 11,309 (0%) | 0% | 157.0 | 83,356 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 531 | 9,563 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 02 Sep 2022 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 04 Aug 2022 | 531 | 11,309 (0%) | 0% | 155 | 82,305 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2022 | 531 | 10,094 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 04 Aug 2022 | 531 | 11,840 (0%) | 0% | 109.5 | 58,118 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 12 Jul 2022 | 532 | 11,309 (0%) | 0% | 155 | 82,460 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2022 | 532 | 10,625 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 12 Jul 2022 | 532 | 11,841 (0%) | 0% | 109.4 | 58,227 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2022 | 8,508 | 11,157 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 27 Jun 2022 | 8,508 | 11,309 (0%) | 0% | 155 | 1,318,740 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 27 Jun 2022 | 8,508 | 19,817 (0%) | 0% | 109.5 | 931,201 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 08 Jun 2022 | 5,835 | 13,961 (0%) | 0% | 155 | 904,425 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.45 per share. | 08 Jun 2022 | 5,835 | 19,796 (0%) | 0% | 109.5 | 638,641 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 5,835 | 19,665 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Internat | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 08 Jun 2022 | 2,652 | 11,309 (0%) | 0% | 155 | 411,060 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Interna | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 3,839 | 15,797 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Interna | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.96 per share. | 03 Mar 2022 | 1,836 | 13,961 (0%) | 0% | 154.0 | 282,671 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.75 per share. | 05 Mar 2021 | 1,402 | 11,958 (0%) | 0% | 164.8 | 230,980 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Samantha Pearce | SVP, Head of Europe & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 3,160 | 13,360 (0%) | 0% | 0 | Ordinary Shares |